Ischemic Stroke Breakthrough: Can Inhibitors Offer New Hope?
Discover the potential of prolyl hydroxylase domain (PHD) inhibitors in ischemic stroke treatment, exploring their multiple mechanisms and therapeutic opportunities. Learn how these inhibitors could offer new hope for stroke patients.